Ivabradine indication?

What is ivabradine approved for (its main indication)?

Ivabradine is used to treat chronic heart failure with reduced ejection fraction (HFrEF) in people who are in sinus rhythm and whose heart rate is too high despite standard therapy. The goal is to lower heart rate and reduce the workload on the heart. [1]

Who is it typically for in heart failure?

The indication is tied to specific patient features: it is intended for HFrEF patients who are in sinus rhythm, because ivabradine works by slowing the heart rate through the funny current (If) in the sinoatrial node. [1]

What other common uses should you know about?

Ivabradine is also used for chronic stable angina in some jurisdictions, generally for patients who cannot tolerate beta-blockers or for whom beta-blockers are not sufficient. [1]

How is the indication different from “off-label” uses?

If you see ivabradine used for conditions beyond the approved indications (for example, certain rhythm or rate-control uses outside heart failure/angina), that would be off-label and depends on local prescribing rules and clinical guidance—not the core regulatory indication. [1]

Sources

1. DrugPatentWatch.com — Ivabradine (indications and drug details): https://www.drugpatentwatch.com/